The long‐term outcome of patients with glycogen storage diseases
| Autor: | Shimon Moses, Gerrit Smit, M. Odievre, J. V. Leonard, Kurt Ullrich, J Fernandes, E. E. Matthews |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
Male
medicine.medical_specialty Adenoma Cardiomyopathy Glycogen storage disease type III Gastroenterology chemistry.chemical_compound Internal medicine Genetics medicine Humans Glycogen storage disease Longitudinal Studies Prospective Studies Child Prospective cohort study Myopathy Genetics (clinical) Glycogen business.industry Incidence Retrospective cohort study Glycogen Storage Disease Prognosis medicine.disease Endocrinology chemistry Female medicine.symptom business |
| Zdroj: | Journal of Inherited Metabolic Disease. 13:411-418 |
| ISSN: | 1573-2665 0141-8955 |
| DOI: | 10.1007/bf01799498 |
| Popis: | In this retrospective study from five centres, 139 patients over 10 years of age with glycogen storage disease types I, III, VI and IX are described. Almost half of the patients with glycogen storage disease type Ia had retarded growth and most had hyperlipidaemia. One-third of the patients had adenomas, although none of these showed malignant transformations. With increasing age the growth, liver size and hyperlipidaemia of patients with glycogen storage disease type III improve. However, there was a high incidence of myopathy and cardiomyopathy. Patients with glycogen storage disease types VI and IX had a normal growth pattern after childhood. Hepatomegaly and hypercholesterolaemia, however, were still present in half of the patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink